Tilray (NASDAQ:TLRY) Trading Down 0.9%

Tilray Inc (NASDAQ:TLRY)’s stock price traded down 0.9% on Wednesday . The company traded as low as $1.67 and last traded at $1.69. 4,531,783 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 25,203,791 shares. The stock had previously closed at $1.70.

Tilray Price Performance

The company has a market cap of $1.43 billion, a PE ratio of -3.86 and a beta of 2.13. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The stock’s 50-day moving average is $1.82 and its 200 day moving average is $1.87.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter in the previous year, the firm posted ($0.15) EPS. Tilray’s revenue was up 24.8% on a year-over-year basis. On average, equities analysts anticipate that Tilray Inc will post -0.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tilray

A number of large investors have recently bought and sold shares of TLRY. Simplicity Wealth LLC purchased a new position in Tilray during the 1st quarter worth approximately $28,000. RPO LLC purchased a new stake in Tilray in the fourth quarter valued at $28,000. Gainplan LLC acquired a new stake in Tilray during the 4th quarter worth about $28,000. Wellington Wealth Strategies LLC. purchased a new position in shares of Tilray during the 4th quarter valued at about $29,000. Finally, HBK Sorce Advisory LLC acquired a new position in shares of Tilray in the 1st quarter valued at about $37,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.